Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2019 065 136.8 |
96 | EP file number | EAKZ | 19 78 2800.7 |
86 | WO file number | WAKZ | PCT/US2019/049027 |
97 | EP publication number | EPN | 3844189 |
87 | WO publication number | WPN | 2020047389 |
54 | Designation/title | TI | DOSIERSTRATEGIE, DIE DAS CYTOKIN-FREISETZUNGSSYNDROM FÜR CD3 / CD20-BISPECIFISCHE-ANTIKÖRPER VERMEIDET |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/573 (2006.01), A61K 39/00 (2006.01) |
22 | DE application date | DAT | Aug 30, 2019 |
96 | EP application date | EAT | Aug 30, 2019 |
86 | WO application date | WAT | Aug 30, 2019 |
43 | Date of first publication | OT | Mar 5, 2020 |
| Date of publication of grant | PET | Jan 22, 2025 |
71/73 | Applicant/owner | INH | Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US |
72 | Inventor | IN | BROWNSTEIN, Carrie, New York, New York 10023, US; LOWY, Israel, Tarrytown, New York 10591, US; ADRIAENS, Lieve Lucille, Tarrytown, New York 10591, US |
| Address for service | | JAK France, 47000 Agen, FR |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862774019 P Nov 30, 2018
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201962861100 P Jun 13, 2019
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862726137 P Aug 31, 2018
|
| Due date | FT FG | Aug 31, 2025 Annual fee for the 7th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003844189A1 Searchable text:
EP000003844189A1 Original document:
EP000003844189B1 Searchable text:
EP000003844189B1 Original document:
WO002020047389 Searchable text:
WO002020047389 |
43 | Date of first publication | EVT | Mar 5, 2020 |
| Date of the first transfer into DPMAregister | EREGT | Jul 7, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 22, 2025 (Show all update days)(Hide all update days)- Jan 22, 2025
- Address for service: changed
- Jan 21, 2025
- Procedures: Publications, DPMA mention of EP grant, 13.02.2025: new
- Jan 3, 2025
- Applicant/owner: new
- Address for service: new
- Due date: new
- Jan 1, 2025
- DE file number : new
- DE application date: new
- Date of publication of grant: new
- Published EP/WO documents: changed
- File number displayed in the result list: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.01.2025: new
- Dec 18, 2024
- Designation/title: changed
- Aug 21, 2024
- Designation/title: changed
- Jul 7, 2021
- Date of the first transfer into DPMAregister
|